Testing New Method of Analyzing MR Images

NCT00630318 | Terminated Phase 1

• 1 other identifier: 0710-67
• Study Type: interventional
• Target: 12
• Locations: 1 country
• Sites: 1

Brief Summary

Preliminary imaging study to test for future use of this MRI-imaging for evaluating anti-angiogenesis treatment.

Conditions

Breast Abnormalities

Keywords

MR scanning

Outcome Measures

Primary Outcomes (1)

• To provide preliminary data for a larger study that this type of imaging can be used to monitor the effectiveness of anti-angiogenic therapy.

  After analysis of images

Interventions

MRI DEVICE

15-20 minutes MR imaging

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Females
• Age 18 years or greater
• Undergoing breast MRI exam

You may not qualify if:

• Pregnancy
• Contraindication for MRI on standard screening checklist for clinically indicated examinations (i.e. metal devices/implants; history of claustrophobia)
• History/presence of any of the following to the breast: injury; breast implant; surgical or interventional procedure; clinically significant abnormality

Sponsors & Collaborators

• Indiana University: lead

Study Sites (1)

Methodist Hospital

Indianapolis, Indiana, 46202, United States

Location

Study Officials

• Susan E. Clare, MD, Ph.D.

  Indiana University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 1
• Allocation: NA
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 28, 2008
• First Posted: March 7, 2008
• Study Start: March 1, 2008
• Primary Completion: July 1, 2010
• Study Completion: July 1, 2010
• Last Updated: January 12, 2017

Record last verified: 2017-01

Locations

US (1)